Randomized, parallel, multicenter, phase IV clinical trial to assess the efficacy of hyaluronic acid/chondroitin sulfate versus fosfomycin trometamol in recurrent urinary tract infection prevention. - INURE
Treatment of Non-severe Confirmed Cases of COVID-19 and Chemoprophylaxis of Their Contacts as Prevention Strategy: a Cluster Randomized Clinical Trial (PEP CoV-2 Study)
This study is a research project to evaluate the efficacy of hydroxychloroquine for post-exposure prophylaxis and early treatment of Covid-19. The intervention entails administering prophylactic hydroxychloroquine to all contacts (Study 1) and treating non severe confirmed cases with hydroxychloroquine (Study 2).
100 Clinical Results associated with Laboratorios Gebro Pharma SA
0 Patents (Medical) associated with Laboratorios Gebro Pharma SA
100 Deals associated with Laboratorios Gebro Pharma SA
100 Translational Medicine associated with Laboratorios Gebro Pharma SA